RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,595 | +6.4% | 1,901 | +19.7% | 0.00% | +100.0% |
| Q2 2023 | $29,696 | +1.9% | 1,588 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $29,140 | -7.3% | 1,588 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $31,442 | -17.7% | 1,588 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $38,207 | +31.8% | 1,588 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $28,981 | +4.8% | 1,588 | +26.3% | 0.00% | 0.0% |
| Q1 2022 | $27,641 | -85.9% | 1,257 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $195,661 | +18.3% | 5,327 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $165,403 | -2.3% | 5,327 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $169,345 | +42.6% | 5,327 | +44.4% | 0.00% | 0.0% |
| Q3 2020 | $118,754 | +11.0% | 3,688 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $107,026 | – | 3,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |